presbyopia

Tenpoint, Visus merge in effort to push presbyopia-correcting eye drop over FDA finish line
Fierce Biotech
Thu, 12/12/24 - 11:38 am
Tenpoint Therapeutics
Visus Therapeutics
presbyopia
M&A
LENZ Therapeutics and Graphite Bio agree to merge
Pharmaceutical Technology
Thu, 11/16/23 - 10:15 am
Graphite Bio
Lenz Therapeutics
M&A
presbyopia
Visus concludes subject enrolment in presbyopia therapy trial
Clinical Trials Arena
Thu, 03/23/23 - 11:42 am
Visus Therapeutics
clinical trials
presbyopia
Brimochol
Novartis drops presbyopia drug acquired with Encore Vision
Pharmaphorum
Tue, 10/25/22 - 10:32 am
Novartis
presbyopia
UNR844
Encore VIsion
AbbVie prices first presbyopia drug Vuity at $80 per month
Pharmaforum
Fri, 12/10/21 - 10:48 am
AbbVie
Vuity
presbyopia
AbbVie claims first FDA okay for presbyopia drug therapy
Pharmaforum
Mon, 11/1/21 - 10:59 am
AbbVie
FDA
presbyopia
AGN-190584
Visus raises $20M ahead of data drop on rival to AbbVie prospect
Fierce Biotech
Tue, 08/10/21 - 10:28 am
Visus Therapeutics
AbbVie
Eyenovia
funding
presbyopia
Allergen builds case for first drug therapy for presbyopia
Pharmaforum
Mon, 07/26/21 - 09:35 am
Allergan
presbyopia
AGN-190584
No more squinting at menus? Visus Therapeutics nabs $36M for presbyopia-correcting eye drop
Endpoints
Tue, 03/9/21 - 10:30 am
Visus Therapeutics
presbyopia
Brimochol
Former Allergan program posts positive topline PhIII results in farsightedness in an R&D win post-AbbVie merger
Endpoints
Wed, 10/28/20 - 10:50 am
Allergan
AbbVie
presbyopia
clinical trials
AGN-190584
Orasis Pharmaceuticals snags $30M to see its presbyopia treatment through to PhIII
Endpoints
Thu, 09/10/20 - 10:41 am
Orasis Pharmaceuticals
presbyopia
Eyedrops Instead of Reading Glasses – Company Begins Ph IIb Trial
CP Wire
Wed, 03/27/19 - 10:16 am
Orasis Pharmaceuticals
clinical trials
presbyopia